Modular trapped-ion quantum computers built by connecting small quantum chips.
DCVC
Activity from announced rounds
DCVC is an investment firm identified by TypeSafe AI as an existing investor and by its own communications as a backer of Shennon Biotechnologies.
Recorded funding activity
TypeSafe turns unstructured inputs into typed decisions and probability scores for automated software. Shennon develops T-cell engager therapies for solid tumors. Separate TypeSafe financings remain separate events under one investor history.
Sources
- Rounds participated in
- 5
- Confirmed lead rounds
- 1 4 roles undisclosed
- New companies
- 5 First participation on record · 0 follow-on
- Funding in participating rounds
- $580M 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
5 in this selectionSoftware infrastructure allowing AI workloads to run across different chips and models
Develops large-scale neutral-atom quantum computers for fault-tolerant commercial and government applications
Builds utility-scale quantum computers using industry-standard silicon transistors
Develops GPS-enabled cattle collars using sensors, software and AI.